logo
Select company
Select metric
$ -3.55EBIT per Share
VS
Market
8
Sector
20
Industry
24
History
82
$ 12.96Close
$ 2.29 - $ 18.94 52-Week Range
Ticker Information

Ticker

PHAT

Company Name

PHATHOM PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PHATHOM PHARMACEUTICALS INC - EBIT per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PHAT - EBITPS Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT per ShareShare FactorWeighted Average Shares
6/30/2025$ -257.49M$ -3.55172.47M
3/31/2025$ -272.88M$ -3.79171.97M
12/31/2024$ -262.32M$ -4.15163.18M
9/30/2024$ -273M$ -4.22164.63M
6/30/2024$ -239.04M$ -4.08158.56M
3/31/2024$ -196.71M$ -3.37158.37M
12/31/2023$ -159.62M$ -3.11151.29M
9/30/2023$ -138.53M$ -2.44156.78M
6/30/2023$ -147.21M$ -3.04148.5M
3/31/2023$ -161.11M$ -3.8142.35M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PHATHOM PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITPS stands at $ -5.07.
  • Over the past 5 years, PHATHOM PHARMACEUTICALS INC's average EBITPS has been $ -3.82.
  • The median EBITPS for PHATHOM PHARMACEUTICALS INC during this period was $ -3.81
  • PHATHOM PHARMACEUTICALS INC reached its highest EBITPS over the past 5 years at $ -2.44.
  • The lowest EBITPS recorded by PHATHOM PHARMACEUTICALS INC in the same timeframe $ -5.07

PHATHOM PHARMACEUTICALS INC's EBITPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITPS Benchmarks
CompanyEBITPS
GYRE : GYRE THERAPEUTICS INC $ 0.08ANAB : ANAPTYSBIO INC $ -4.6NAGE : NIAGEN BIOSCIENCE INC $ 0.23CRMD : CORMEDIX INC $ 0.76TBPH : THERAVANCE BIOPHARMA INC $ 0.85ZYME : ZYMEWORKS INC $ -0.89URGN : UROGEN PHARMA LTD $ -2.85ZVRA : ZEVRA THERAPEUTICS INC $ 0.55XNCR : XENCOR INC $ -1.81KURA : KURA ONCOLOGY INC $ -2.21

Definition of EBIT per Share

[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBIT / (Shares WA * Share Factor)
(=) EBITPS
EBITPS for PHATHOM PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -169.03M ] / (Shares WA [ 33.37M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -5.07 ]

PHAT - EBIT per Share, Last 5 years

$ -5.07

Minimum

Sep 30, 2020

$ -2.44

Maximum

Sep 30, 2023

$ -3.82

Average

$ -3.81

Median

EBITPS Benchmark Analysis

The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.41.
The following table provides additional summary stats:
EBITPS in the Market:
filtered constituents3.79K
min$ -9.71
max$ 10.76
average$ 1.16
median$ 0.39
std$ 3.41